SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-18-028453
Filing Date
2018-09-27
Accepted
2018-09-27 16:16:34
Documents
1
Period of Report
2018-09-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3041
  Complete submission text file 0001127602-18-028453.txt   4663
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Issuer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O BIOGEN INC. 225 BINNEY ST. CAMBRIDGE MA 02142
Business Address
Ehlers Michael D (Reporting) CIK: 0001674364 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19311 | Film No.: 181091156